Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer

NCT05806814 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Interventions

BIOLOGICAL: Sipuleucel-T

Sponsor

University of Oklahoma

Collaborators

[object Object]